Pirarubicin
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
(3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranoside
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Identifiers | |
CAS Number | 72496-41-4 |
ATC code | L01DB08 (WHO) |
PubChem | CID: 3033521 |
ChemSpider | 2298189 |
UNII | D58G680W0G |
KEGG | D01885 |
ChEMBL | CHEMBL1398373 |
Synonyms | (9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
Chemical data | |
Formula | C32H37NO12 |
Molecular mass | 627.63 g/mol |
|
|
|
|
(what is this?) (verify) |
Pirarubicin (INN) is an anthracycline drug. An analogue of the anthracycline antineoplastic antibiotic doxorubicin. Pirarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent is less cardiotoxic than doxorubicin and exhibits activity against some doxorubicin-resistant cell lines.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Anthracyclines
- Topoisomerase inhibitors
- Tetrahydropyrans
- Phenols
- Phenol ethers
- Antineoplastic and immunomodulating drug stubs